Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
50%(3 trials)

Phase Distribution

Ph phase_1
1
17%
Ph phase_4
3
50%
Ph phase_2
1
17%
Ph not_applicable
1
17%

Phase Distribution

1

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 4Post-market surveillance
3(50.0%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(6)

Detailed Status

Completed6

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (16.7%)
Phase 21 (16.7%)
Phase 43 (50.0%)
N/A1 (16.7%)

Trials by Status

completed6100%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_2

Investigate Dose of Org 36286 to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or IVF/ICSI (P07015)

NCT00702806
completedphase_1

Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD

NCT02525029
completedphase_4

Co Administration of GnRH Agonist and hCG for Final Oocyte Maturation

NCT02703584
completednot_applicable

Implantation Enhancement by Elective Cryopreservation of All Viable Embryos

NCT02148393
completedphase_4

Trial Comparing hCG Triggering Versus hCG Associated With GnRH Agonist

NCT01607203
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT00702806Phase 2

Investigate Dose of Org 36286 to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or IVF/ICSI (P07015)

Completed
NCT02525029Phase 1

Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD

Completed
NCT02703584Phase 4

Co Administration of GnRH Agonist and hCG for Final Oocyte Maturation

Completed
NCT02148393Not Applicable

Implantation Enhancement by Elective Cryopreservation of All Viable Embryos

Completed
NCT01607203Phase 4

Trial Comparing hCG Triggering Versus hCG Associated With GnRH Agonist

Completed
NCT00627406Phase 4

Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6